ArticleBioMed research international2026
Association of miR-499, miR-27a, and miR-34a Gene Polymorphisms With Susceptibility to Type 2 Diabetes Mellitus in an Iranian Population: A Case-Control Study.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundType 2 diabetes mellitus (T2DM) is a multifactorial metabolic disorder influenced by both environmental and genetic factors. MicroRNAs (miRNAs) are involved in the regulation of insulin signaling, inflammation, and pancreatic β-cell function. Genetic polymorphisms in miRNA-related regions may contribute to interindividual differences in T2DM susceptibility, although their functional effects remain uncertain.
objectiveThis study is aimed at evaluating the association of five miRNA polymorphisms, miR-499 rs3746444, miR-27a rs895819/rs895519, miR-34a rs6577555, miR-124a rs531564, and miR-146a rs2910164, with susceptibility to T2DM in an Iranian population.
methodsThis case-control study included 200 patients with T2DM and 202 unrelated healthy controls from southeastern Iran. Genotyping was performed using T-ARMS-PCR and PCR-RFLP methods. Genotype and allele distributions were compared between groups, Hardy-Weinberg equilibrium was assessed in controls, and crude odds ratios (ORs) were calculated under different genetic models. Multivariable logistic regression was also performed to estimate age- and sex-adjusted ORs. Bonferroni correction was applied to account for multiple comparisons.
resultsSignificant associations with increased T2DM risk were observed for miR-499 rs3746444 C allele (OR = 1.79, 95% CI = 1.34-2.39; p < 0.001), miR-27a rs895819 G allele (OR = 1.89, 95% CI = 1.43-2.51; p < 0.001), and miR-34a rs6577555 A allele (OR = 2.91, 95% CI = 2.19-3.88; p < 0.001). These associations remained evident in age- and sex-adjusted codominant logistic regression models. In contrast, miR-124a rs531564 and miR-146a rs2910164 were not significantly associated with T2DM risk.
conclusionThe findings suggest that miR-499 rs3746444, miR-27a rs895819/rs895519, and miR-34a rs6577555 polymorphisms are associated with T2DM susceptibility in this Iranian population. However, these results indicate association rather than causation, and further large-scale, multiethnic, and functional studies are needed to confirm their biological and clinical relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.